Capsule Endoscopy Market Report 2026

The capsule endoscopy market size has grown rapidly in recent years. It will grow from $0.76 billion in 2025 to $0.84 billion in 2026 at a compound annual growth rate (CAGR) of 11%. The growth in the historic period can be attributed to increasing incidence of gastrointestinal disorders, limitations of conventional endoscopy procedures, rising preference for non-invasive diagnostics, expansion of hospital diagnostic capabilities, improved capsule imaging technologies.

The capsule endoscopy market size is expected to see rapid growth in the next few years. It will grow to $1.26 billion in 2030 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to increasing demand for early disease detection, rising adoption of ai-enabled diagnostics, expansion of outpatient diagnostic services, growing investments in digital healthcare platforms, increasing focus on patient-centric diagnostic solutions. Major trends in the forecast period include increasing adoption of wireless capsule imaging systems, rising use of AI-assisted image interpretation, growing demand for minimally invasive diagnostic procedures, expansion of specialty capsule applications, enhanced integration of software-based diagnostic platforms.

The rising prevalence of gastrointestinal illnesses is expected to drive the growth of the capsule endoscopy market in the coming years. Gastrointestinal (GI) illnesses are disorders that affect the digestive system, including conditions such as indigestion, inflammatory bowel disease (IBD), and gastrointestinal cancers. This increasing prevalence can be linked to factors like poor dietary habits, stress, sedentary lifestyles, overuse of antibiotics, an aging population, environmental pollutants, antibiotic resistance, and disruptions in the gut microbiome. Capsule endoscopy offers a non-invasive and detailed examination of the gastrointestinal tract, facilitating early diagnosis and better management of conditions such as Crohn’s disease, ulcers, and gastrointestinal bleeding. For example, in December 2023, data from the IBD Registry, a UK-based non-profit organization, indicated that the number of individuals with Inflammatory Bowel Disease (IBD) had exceeded 5,300, representing an increase of more than 3,000 members compared to the previous year (2022). Consequently, the growing prevalence of gastrointestinal illnesses is fueling the expansion of the capsule endoscopy market.

The increasing healthcare expenditure is anticipated to drive the growth of the capsule endoscopy market in the coming years. Healthcare expenditure refers to the total financial resources allocated by individuals, organizations, or governments for preventing, treating, and managing health conditions. Healthcare spending is rising due to advancements in medical technology, as new diagnostic tools, treatments, and innovative therapies often involve higher costs, resulting in greater overall healthcare spending. Higher healthcare expenditure facilitates wider adoption, improved patient access, and technological progress in capsule endoscopy, enhancing its clinical and market impact. For example, in December 2024, according to the Centers for Medicare & Medicaid Services, a U.S.-based agency responsible for administering Medicare and Medicaid programs, U.S. healthcare expenditures increased by 7.5% in 2023, reaching $4.9 trillion, or approximately $14,570 per individual. Consequently, the growing healthcare expenditure is supporting the expansion of the capsule endoscopy market.

Major companies in the capsule endoscopy market are concentrating on developing innovative technologies, such as magnetically controlled capsule endoscopy systems, to improve diagnostic precision, enhance patient comfort, and broaden the applications of gastrointestinal imaging. Magnetically controlled capsule endoscopy systems are sophisticated diagnostic devices that use external magnetic fields to accurately guide a swallowable camera capsule through the gastrointestinal tract, providing non-invasive and detailed imaging. For example, in February 2023, AnX Robotica Corporation, a US-based medical equipment manufacturer, introduced the NaviCam Small Bowel System to improve visualization of the small bowel, which is essential for diagnosing various gastrointestinal conditions. This advanced system features a magnetically controlled capsule with high-definition imaging capabilities, allowing real-time navigation and visualization of the small bowel. The system also incorporates AI-powered analytics for fast and precise detection of abnormalities, streamlining the diagnostic workflow. With its non-invasive method and cutting-edge technology, the NaviCam Small Bowel System establishes a new standard for efficiency and effectiveness in gastrointestinal healthcare.

Major companies operating in the capsule endoscopy market are Medtronic plc, Fujifilm Holdings Corporation, Olympus Corporation, CapsoVision Inc., Check-Cap Ltd., IntroMedic Co. Ltd., Ankon Technologies Co. Ltd., AnX Robotica Corporation, RF System Lab Co. Ltd., AccuRead Endoscopy Inc., Chongqing Jinshan Science and Technology Group Co. Ltd., Anhan Technology Co. Ltd., SynMed Medical Technology Co. Ltd., Shengxian Minimal Invasive Inc., BioCam Inc., JIFU Medical Technology Co. Ltd., OMOM Medical Technology Co. Ltd., Shanghai iRay Technology Co. Ltd., Shenzhen Wision Medical Technology Co. Ltd., Zhejiang Chuangxiang Medical Technology Co. Ltd.

North America was the largest region in the capsule endoscopy market in 2025. The regions covered in the capsule endoscopy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the capsule endoscopy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the capsule endoscopy market by increasing costs of imported electronic components, imaging sensors, batteries, software platforms, and precision manufacturing equipment used in capsule devices and associated systems. Hospitals and diagnostic centers in North America and Europe are most affected due to reliance on imported high-tech medical components, while Asia-Pacific faces pricing pressure on device manufacturing and exports. These tariffs raise procurement costs and may delay technology upgrades. At the same time, they encourage localized device assembly, regional component sourcing, and domestic innovation in capsule endoscopy technologies.

The capsule endoscopy market research report is one of a series of new reports that provides capsule endoscopy market statistics, including capsule endoscopy industry global market size, regional shares, competitors with a capsule endoscopy market share, detailed capsule endoscopy market segments, market trends and opportunities, and any further data you may need to thrive in the capsule endoscopy industry. This capsule endoscopy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Capsule endoscopy is a minimally invasive diagnostic procedure in which a small, pill-sized camera is ingested to capture images of the gastrointestinal (GI) tract. It helps identify conditions such as bleeding, ulcers, and inflammatory bowel diseases, offering detailed visuals of areas that are challenging to reach with traditional endoscopy.

The primary products in capsule endoscopy include capsule endoscopes and related systems. Capsule endoscopes are small, pill-sized devices equipped with cameras that are swallowed to obtain images of the digestive tract for diagnosing gastrointestinal conditions. These devices are applied in various areas, including obscure gastrointestinal bleeding (OGIB), Crohn's disease, small intestine tumors, and others, and are utilized by a range of end users such as hospitals, diagnostic laboratories, and specialty clinics.

The capsule endoscopy market consists of sales of image recorder, software for image analysis, data management systems, retrieval kits, and biopsy tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.